William Pryor: “I have a letter from Donna Shalala, the Secretary of HHS, and I quote…”

On the recordJune 27, 1996

I have a letter from Donna Shalala, the Secretary of HHS, and I quote from the letter that has been distributed throughout the Senate this afternoon. Secretary Shalala says: It will be nearly impossible to meet the substantial investment requirement under the Hatch substitute. She concludes saying: It would be virtually impossible for a manufacturer to obtain FDA approval for a generic drug product during this transition period.

Said by

William Pryor

Source

govinfo.gov

Editor's note · Context

Discussing concerns about the Hatch substitute related to FDA approval for generic drugs.

Share on X Share on Facebook Email this quote

More from William Pryor

Mar 13, 2008

This is amendment No. 4181. The cosponsors are Senators Snowe, Bingaman, and Kerry. It is a deficit-neutral reserve fund for science parks. These are sometimes called technology parks or business incubators. But there is no doubt these…

govinfo.gov

Mar 6, 2008

No. First, the CPSC Reform Act bans lead in children's products beyond trace amounts. Under section 22, any children's product that contains lead ``shall be treated as a banned hazardous substance under the Federal Hazardous Substances…

govinfo.gov

Mar 5, 2008

I was encouraged yesterday by the vote we had at 5:30. Here, again, we find that the Consumer Product Safety Commission is an agency that needs our reform. They need us to come in and to not just give them more resources--it is not a…

govinfo.gov

Dec 17, 2023

Whatever the chief of staff's role with respect to state election administration does not include altering valid election results.

transcripts.cnn.com

View all William Pryor quotes

William Pryor: “I have a letter from Donna Shalala, the Secretary of HHS, and I quote from the letter that has been distributed…”

Editor's note · Context